| Mrs Alicia Lynn Lutman, OTD, MS, OTR/L, ATC | |
|
600 N Main St Ste 200, Woodstock, VA 22664-1855 | |
| (540) 459-6222 | |
| Not Available |
| Full Name | Mrs Alicia Lynn Lutman |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 600 N Main St Ste 200, Woodstock, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962667196 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 0119004262 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Alicia Lynn Lutman, OTD, MS, OTR/L, ATC 600 N Main St Ste 200, Woodstock, VA 22664-1855 Ph: (540) 459-6222 | Mrs Alicia Lynn Lutman, OTD, MS, OTR/L, ATC 600 N Main St Ste 200, Woodstock, VA 22664-1855 Ph: (540) 459-6222 |
News Archive
Are you overweight and living in the South East of England? If so, you could help scientists who need volunteers to test a new 'fat pill'.
Child protection, reproductive choices, infant feeding and teenage parenthood (including planned teenage pregnancy and positive experiences of teenage motherhood) are among the topics to be discussed at an international conference on childrearing in the age of ‘intensive parenting'.
Results of an international clinical study conducted in Europe and the US presented today at the International Liver CongressTM 2010, the Annual Meeting of the European Association for the Study of Liver in Vienna, Austria, have identified a genomic portrait able to predict recurrence in hepatocellular carcinoma (HCC), the fifth most common cancer in men.
Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine's efficacy in treating asthma patients and is not currently approved for this indication.
› Verified 5 days ago
Dr. Heather Kennell Pugh, MA, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2975 Jadwyn Rd, Woodstock, VA 22664 Phone: 540-247-9896 | |
Mrs. Sarah Henderson Riner, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 137 Flora Vista Ln, Woodstock, VA 22664 Phone: 540-335-8648 | |
Kimberly Anderson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 803 S Main St, Woodstock, VA 22664 Phone: 540-459-5676 | |
Kara Rajana Jeffrey, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 517 W Court St, Woodstock, VA 22664 Phone: 540-459-4381 |